Cargando…

Clinical characteristics and outcome of SARS –CoV-2 infection in patients with cystic fibrosis managed at home

Detalles Bibliográficos
Autores principales:	Terlizzi, V., Francalanci, M., Taccetti, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590936/ https://www.ncbi.nlm.nih.gov/pubmed/34852971 http://dx.doi.org/10.1016/j.pulmoe.2021.10.006

Ejemplares similares

P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany
por: Dolce, D., et al.
Publicado: (2021)

Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice
por: Terlizzi, Vito, et al.
Publicado: (2021)

G378X‐I148T CFTR variant: A new complex allele in a cystic fibrosis newborn with pancreatic insufficiency
por: Terlizzi, Vito, et al.
Publicado: (2022)

First and second wave of SARS-CoV2 in Italian Cystic Fibrosis patients: Data from Italian Cystic Fibrosis Registry
por: Padoan, Rita, et al.
Publicado: (2021)

No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy
por: Scagnolari, Carolina, et al.
Publicado: (2020)

Clinical characteristics and outcome of SARS-CoV-2 infection during pregnancy
por: Liu, Yangli, et al.
Publicado: (2021)

Cystic fibrosis in Tuscany: evolution of newborn screening strategies over time to the present
por: Botti, Matteo, et al.
Publicado: (2021)

Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
por: Taccetti, Giovanni, et al.
Publicado: (2021)

Characteristics of SARS-CoV-2 super-spreaders in Japan
por: Kawahara, Tomoki, et al.
Publicado: (2022)

Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
por: Li, Xiaofei
Publicado: (2021)

Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index
por: Terlizzi, Vito, et al.
Publicado: (2022)

Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
por: López-Mendez, Ivan, et al.
Publicado: (2021)

Characteristics of SARS-CoV-2 exhaled by COVID-19 patients
por: Lina, Liu, et al.
Publicado: (2023)

Managing halitosis during the SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

Home-based SARS-CoV-2 lateral flow antigen testing in hospital workers
por: Downs, Louise O, et al.
Publicado: (2021)

Care home SARS-CoV-2 outbreaks are highly dependent on the immunocompetence of the infected people
por: Finsterer, J.
Publicado: (2023)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Clinical and biochemical characteristics of patients admitted to ICU with SARS-CoV-2
por: Blake, A., et al.
Publicado: (2020)

Clinical and biochemical characteristics of patients admitted to ICU with SARS-CoV-2
por: Blake, A., et al.
Publicado: (2020)

The role of povidone-iodine in managing of SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Managing SARS-CoV-2 outbreak challenges in psychiatric hospitals of Bangladesh
por: Kushal, Sayedul Ashraf, et al.
Publicado: (2020)

Managing intentional replantation of teeth during the SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2023)

Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor Therapy in Three Subjects with the Cystic Fibrosis Genotype Phe508del/Unknown and Advanced Lung Disease
por: Terlizzi, Vito, et al.
Publicado: (2021)

Early detection of SARS-CoV-2 infection cases or outbreaks at nursing homes by targeted wastewater tracking
por: Davó, Laura, et al.
Publicado: (2021)

Comparison between Gibson–Cooke and Macroduct Methods in the Cystic Fibrosis Neonatal Screening Program and in Subjects Who Are Cystic Fibrosis Screen-Positive with an Inconclusive Diagnosis
por: Dolce, Daniela, et al.
Publicado: (2023)

SARS-CoV-2 and Legionella Co-Infection
por: Gauvin, Caitlin A., et al.
Publicado: (2023)

Clinical Features and Outcomes of Asymptomatic Cases of SARS-CoV-2 Infection
por: Wu, Jianguo, et al.
Publicado: (2020)

Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2
por: Gulmez, Ali Osman, et al.
Publicado: (2023)

A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
por: Xie, Dongying, et al.
Publicado: (2021)

SARS CoV-2 genetic jump to a new SARS CoV-3 pandemic: Let’s be prepared
por: Kelleni, Mina T.
Publicado: (2023)

51 Outcomes after SARS-CoV-2 infection in Canadians with cystic fibrosis: Analyses using the Canadian Cystic Fibrosis Registry
por: Cheng, S., et al.
Publicado: (2022)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

SARS‐CoV‐2 immunogenicity at the crossroads
por: Karamloo, Fariba, et al.
Publicado: (2020)

Transmission routes of SARS-CoV-2
por: Patel, Jay
Publicado: (2020)

SARS-CoV-2 and EBV coinfection()
por: García-Martínez, Francisco Javier, et al.
Publicado: (2020)

Peptide Targets to SARS-CoV-2
por: Mandal, Santi M.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o4uho86u1mml4ro2kjb2hdlk2i